Skip to main content
SpringerLink
Log in

Uveal Malignant Melanoma: Histopathologic Features

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

  • 816 Accesses

Abstract

Uveal melanomas develop from melanocytes that reside within the stroma of the choroid, ciliary body, and iris. No basement membrane needs to be breached when the tumor develops [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Folberg R. Tumor progression in ocular melanomas. J Invest Dermatol. 1993;100(3):326S–31.

    Article  CAS  PubMed  Google Scholar 

  2. Reese AB, Howard GM. Flat uveal melanomas. Am J Ophthalmol. 1967;64(6):1021–8.

    CAS  PubMed  Google Scholar 

  3. Demirci H, Shields CL, Shields JA, Honavar SG, Eagle Jr RC. Ring melanoma of the ciliary body: report on twenty-three patients. Retina. 2002;22(6):698–706; quiz 852–3.

    Article  PubMed  Google Scholar 

  4. Kivelä T, Summanen P. Retinoinvasive malignant melanoma of the uvea. Br J Ophthalmol. 1997;81(8):691–7.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115(10):1778–85.

    Article  PubMed  Google Scholar 

  6. van Beek JG, Koopmans AE, Vaarwater J, de Rooi JJ, Paridaens D, Naus NC, et al. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma. Invest Ophthalmol Vis Sci. 2014;55(3):1284–91.

    Article  PubMed  Google Scholar 

  7. Muen WJ, Damato BE. Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy. Eye (Lond). 2007;21(2):307–8.

    Article  CAS  Google Scholar 

  8. Spencer WH. Optic nerve extension of intraocular neoplasms. Am J Ophthalmol. 1975;80(3 Pt 1):465–71.

    CAS  PubMed  Google Scholar 

  9. Kivelä T, Eskelin S, Mäkitie T, Summanen P. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci. 2001;42(9):2085–93.

    PubMed  Google Scholar 

  10. McMenamin PG, Lee WR. Ultrastructural pathology of melanomalytic glaucoma. Br J Ophthalmol. 1986;70(12):895–906.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Callender GR. Malignant melanocytic tumors of the eye. A study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol. 1931;36:131–40.

    Google Scholar 

  12. McLean IW, Zimmerman LE, Evans RM. Reappraisal of Callender’s spindle A type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 1978;86(4):557–64.

    CAS  PubMed  Google Scholar 

  13. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender’s classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983;96(4):502–9.

    CAS  PubMed  Google Scholar 

  14. Moshari A, McLean IW. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections. Invest Ophthalmol Vis Sci. 2001;42(6):1160–3.

    CAS  PubMed  Google Scholar 

  15. McLean IW, Keefe KS, Burnier MN. Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology. 1997;104(5):777–80.

    Article  CAS  PubMed  Google Scholar 

  16. Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology. 1998;105(3):485–91.

    Article  CAS  PubMed  Google Scholar 

  17. Al-Jamal RT, Mäkitie T, Kivelä T. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body. Invest Ophthalmol Vis Sci. 2003;44(6):2381–9.

    Article  PubMed  Google Scholar 

  18. Folberg R, Rummelt V, Parys-van Ginderdeuren R, Hwang T, Woolson RF, Pe’er J, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100(9):1389–98.

    Article  CAS  PubMed  Google Scholar 

  19. Folberg R, Pe’er J, Gruman LM, Woolson RF, Jeng G, Montague PR, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23(11):1298–305.

    Article  CAS  PubMed  Google Scholar 

  20. Rummelt V, Folberg R, Rummelt C, Gruman LM, Hwang T, Woolson RF, et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study. Ophthalmology. 1994;101(4):718–27.

    Article  CAS  PubMed  Google Scholar 

  21. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst. 1999;91(4):359–67.

    Article  PubMed  Google Scholar 

  22. Kivelä T. Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology. Br J Biomed Sci. 1995;52(4):325–6.

    PubMed  Google Scholar 

  23. Foss AJ, Alexander RA, Jefferies LW, Hungerford JL, Harris AL, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res. 1996;56(13):2900–3.

    CAS  PubMed  Google Scholar 

  24. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999;40(11):2471–80.

    PubMed  Google Scholar 

  25. Chen X, Maniotis AJ, Majumdar D, Pe’er J, Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci. 2002;43(8):2533–9.

    PubMed  Google Scholar 

  26. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42(7):1414–21.

    PubMed  Google Scholar 

  27. de la Cruz Jr PO, Specht CS, McLean IW. Lymphocytic infiltration in uveal malignant melanoma. Cancer. 1990;65(1):112–5.

    Article  PubMed  Google Scholar 

  28. Al-Jamal RT, Kivelä T. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors. Curr Eye Res. 2006;31(1):57–67.

    Article  CAS  PubMed  Google Scholar 

  29. Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Invest Ophthalmol Vis Sci. 1997;38(9):1865–72.

    CAS  PubMed  Google Scholar 

  30. Fuchs U, Kivelä T, Summanen P, Immonen I, Tarkkanen A. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol. 1992;141(1):169–81.

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Hendrix MJ, Seftor EA, Seftor RE, Gardner LM, Boldt HC, Meyer M, et al. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. Lab Invest. 1998;78(2):153–63.

    CAS  PubMed  Google Scholar 

  32. Shah AA, Bourne TD, Murali R. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Pathology. 2013;45(7):651–6.

    Article  CAS  PubMed  Google Scholar 

  33. Koopmans AE, Verdijk RM, Brouwer RWW, van den Bosch TPP, van den Berg MMP, Vaarvater J, et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol. 2014 [Epub ahead of print].

    Google Scholar 

  34. Toivonen P, Mäkitie T, Kujala E, Kivelä T. Macrophages and microcirculation in regressed and partially regressed irradiated choroidal and ciliary body melanomas. Curr Eye Res. 2003;27(4):237–45.

    Article  PubMed  Google Scholar 

  35. Fuchs U, Kivelä T, Tarkkanen A, Laatikainen L. Histopathology of enucleated intraocular melanomas irradiated with cobalt and ruthenium plaques. Acta Ophthalmol (Copenh). 1988;66(3):255–66.

    Article  CAS  Google Scholar 

  36. Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992;110(8):1112–8.

    Article  CAS  PubMed  Google Scholar 

  37. Toivonen P, Mäkitie T, Kujala E, Kivelä T. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci. 2004;45(1):1–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Helsinki University Central Hospital, Haartmaninkatu 4 C, PL 220, FI-00029 HUS, Helsinki, Finland

    Tero Kivelä MD, FEBO

Authors
  1. Tero Kivelä MD, FEBO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tero Kivelä MD, FEBO .

Editor information

Editors and Affiliations

  1. Ocular Oncology Service, Departments of Ophthalmology and Radiation Oncology, University of California, San Francisco, San Francisco, California, USA

    Bertil Damato

  2. Dept. of Ophthalmic Oncology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Arun D. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kivelä, T. (2014). Uveal Malignant Melanoma: Histopathologic Features. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54255-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54255-8_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54254-1

  • Online ISBN: 978-3-642-54255-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation